Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of hard-to-treat disease in a unique and transformative approach to drug discovery and development.

Biotechnology

Alchemab Therapeutics

Young Kwon

Becky Eretta

Alexander Hewitson

Henry Farmery

Paul Varley

Donna Finch

Olivia Cavlan

Jane Osbourn

Peter Catalano

Jenny Howell

Jake Galson

Ralph Minter

The board of directors at Alchemab Therapeutics has a history of experience in the biotech and pharmaceutical industries, as well as experience in venture capital and investments. The board members have also lectured at universities, including the University of California, Davis Graduate School of Management.

Board of Directors

Leadership Team

CEO and Executive Team

Board of Directors

About

Team members

Other teams at Alchemab Therapeutics

Leadership Team

CEO and Executive Team